Discussion of "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes"
Biometrics
.
2021 Dec;77(4):1485-1488.
doi: 10.1111/biom.13492.
Epub 2021 Jun 9.
Authors
Min Zhang
1
,
Baqun Zhang
2
Affiliations
1
Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
2
School of Statistics and Management, Shanghai University of Finance and Economics, Shanghai, People's Republic of China.
PMID:
34105765
PMCID:
PMC8239578
DOI:
10.1111/biom.13492
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Drug Treatment*
Data Interpretation, Statistical
Humans
Randomized Controlled Trials as Topic
SARS-CoV-2